Compensation award — excluded from discretionary-purchase analysis.
Traded Sep 8, 2026 · Filed Sep 10, 2026
West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $852K of West Pharmaceutical Services shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$852,025
Shares × reported transaction price
47 days after results of Jul 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $337.75 on Sep 8, 2026, 46% above its 52-week low and 8% below its high, after a 2% rise over the previous 30 trading days
52-week range $230.95 (Feb 3, 2026) to $365.74 (Jul 2, 2026), 79% of the way up, from 251 adjusted closes. 30 trading days earlier: $331.25 on Jul 27, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on May 5, 2025 in the U.S. District Court, E.D. Pennsylvania. A filing is an allegation, not a finding.
NEW ENGLAND TEAMSTERS PENSION FUND v. WEST PHARMACEUTICAL SERVICES, INC., docket 2:25-cv-02285, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.6% | -0.3% | +5.0% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
24K → 22K shares held−10% of their stake
West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $863K of West Pharmaceutical Services shares. Nobody planned it ahead of time.